ALPG and pancreatic neoplasm: A study showed that a pancreatic cancer-specific RNA aptamer can be used for the targeted drug delivery of the nucleoside drug 5-fluoro-2’-deoxyuridine to pancreatic cancer cells expressing alkaline phosphatase placental-like 2, a putative biomarker, leading to the inhibition of tumor growth [103].